Relationship of standardized mitotic indices to other prognostic factors in breast cancer

Archives of Pathology and Laboratory Medicine

Volumn 120, Issue 5, 1996, Pages 473-477

  Gaffney II, Edwin V ^a   Venz Williamson, Teresa L ^b   Hutchinson, Gloria ^b   Biggs, Paul J ^b   Nelson, Karl M ^b  

^a Deaconess Research Institute   (United States)

^b Baptist Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BONE SCINTISCANNING; BREAST CANCER; CALCULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MITOSIS; PROGNOSIS; STANDARDIZATION; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CELL COUNT; FEMALE; HUMANS; MIDDLE AGED; MITOTIC INDEX; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES;

EID: 0029974197     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aaltomaa S, Lipponen P, Eskelinen M. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer. Eur J Surg. 1991;157:319-324.
2. Baak JPA, Van Dop H, Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer. 1985;56:374-382.
3. Eskelinen M, Kosma V-M, Marin S. Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol. 1992;118:75-81.
4. Van Diest PJ, Baak JPA, Matze-cok P. Reproducibility of mitosis counting in 2,469 breast cancer specimens. Hum Pathol. 1992;23:603-607.
5. Clayton F, Hopkins CL. Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer. 1993;71:1780-1790.
6. Collan Y, Torskeli T, Kosma V-M. Sampling in diagnostic morphometry: the influence of variation sources. Pathol Res Pract. 1987;182:401-406.
7. Ellis PSJ, Whitehead R. Mitosis counting: a need for reappraisal. Hum Pathol. 1981;12:3-4.
8. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer. 1957;11:359-377.
9. Elston CW. Grading of invasive carcinoma of the breast. In Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Edinburgh, Scotland: Churchill Livingstone; 1988:300-311.
10. Baak JPA, Oort J. A Manual of Morphometry in Diagnostic Pathology. New York, NY: Springer-Verlag; 1983.
11. Clark GM, Dressler LG, Owens MA. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med. 1989;320:627-633.
12. Wilkinson L, Hill M, Welna JP, Birkenbenel GK. SYSTAT for Windows: statistics. Version 5 ed. Evanston, III: SYSTAT, Inc; 1992.
13. Eskelinen M, Collan Y, Pajarinen P. An improved prognostic index of axillary node involvement in breast cancer incorporating DNA ploidy and tumor size. Acta Clin Scand. 1990;156:521-527.
14. Parham DM, Hagen H, Brown RA. Simplified method of grading primary carcinomas of the breast. J Clin Pathol. 1990;45:517-520.
15. Elston CW, Ellis IO. Pathology and breast screening. Histopathology. 1990;16:109-118.
16. Toikkanen S, Joensun H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer: a study with long term follow-up. Br J Cancer. 1989;60:693-700.
17. Dressler LG, Seamer LC, Owens MA. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer. 1988;61:420-427.
18. Kallioniemi OP, Blanco G, Alavaikko M. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: a proposed classification of DNA histograms in breast cancer. Cancer. 1988;62:2183-2190.
19. Weidner N, Moore DH, Ljung B-M. Correlation of bromodeoxyuridine (BRDU) labelling of breast carcinoma cells with mitotic figure content and tumor grade. Am J Surg Pathol. 1993;17:987-994.
20. 3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer. J Clin Oncol. 1990;8:1321-1326.
21. Goodson WH, Ljung B-M, Waldman F. In vivo measurement of breast cancer growth rate. Arch Surg. 1991;126:1220-1224.
22. Meyer JS, Rao BR, Stevens SC. Low incidence of estrogen receptor in breast carcinoma with rapid rates of cellular replication. Cancer. 1977;40:2290-2298.
23. Silvestrini R, Daidone MG, DiFronzo G. Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer. 1979;44:665-670.